Androgel®, Singapore - Shim Clinic
Androgel®
Latest News
AbbVie hit with $140 million verdict in AndroGel trial: lawyerFri, 06 Oct 2017 04:50:37 +0800 | Reuters: Health
(Reuters) - A U.S. jury on Thursday ordered AbbVie Inc to pay more than $140 million to a man who claimed the company misrepresented the risks of its testosterone replacement drug AndroGel, causing him to suffer a heart attack, the plaintiff's lawyer said in an emailed statement. (Source: Reuters: Health)
Dose-Response Effects of T Gel in Medically Castrated Men Dose-Response Effects of T Gel in Medically Castrated Men
Thu, 21 Sep 2017 11:14:34 +0800 | Medscape Today Headlines
A new study examines the treatment effects of variable doses of transdermal testosterone gel among medically castrated men.Clinical Endocrinology (Source: Medscape Today Headlines)
U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict U.S. Jury Finds AbbVie Liable for Misrepresentation in First AndroGel Verdict
Wed, 26 Jul 2017 03:12:48 +0800 | Medscape Medical News Headlines
A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages.Reuters Health Information (Source: Medscape Medical News Headlines)
U.S. jury finds AbbVie liable for misrepresentation in AndroGel verdict
Tue, 25 Jul 2017 03:44:19 +0800 | Reuters: Health
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
U.S. jury finds AbbVie liable for misrepresentation in first AndroGel verdict
Tue, 25 Jul 2017 01:45:12 +0800 | Reuters: Health
NEW YORK (Reuters) - A federal jury in Chicago on Monday found AbbVie Inc fraudulently misrepresented the risks of its testosterone replacement drug AndroGel and ordered the drugmaker to pay $150 million in punitive damages. (Source: Reuters: Health)
Testosterone Replacement Gel Therapy for Male Hypogonadism Testosterone Replacement Gel Therapy for Male Hypogonadism
Fri, 14 Jul 2017 12:14:48 +0800 | Medscape Today Headlines
This novel testosterone gel formulation may be an effective new treatment option for hypogonadal men.Endocrine Practice (Source: Medscape Today Headlines)
Axiron vs. Androgel
Wed, 19 Apr 2017 14:00:00 +0800 | MedicineNet Medications General
Title: Axiron vs. AndrogelCategory: MedicationsCreated: 4/19/2017 12:00:00 AMLast Editorial Review: 4/19/2017 12:00:00 AM (Source: MedicineNet Medications General)
Axiron vs. Androgel Testosterone Supplements
Tue, 18 Apr 2017 14:00:00 +0800 | MedicineNet Medications General
Title: Axiron vs. Androgel Testosterone SupplementsCategory: MedicationsCreated: 4/18/2017 12:00:00 AMLast Editorial Review: 4/18/2017 12:00:00 AM (Source: MedicineNet Medications General)
Morning Report: Vertigo, Insect Repellents, Testosterone Gel Morning Report: Vertigo, Insect Repellents, Testosterone Gel
Fri, 10 Mar 2017 22:53:35 +0800 | Medscape Today Headlines
Dr Arefa Cassoobhoy highlights some of this week's most important medical news.Medscape Internal Medicine (Source: Medscape Today Headlines)
Testosterone Therapy: Five New Reports Offer a Mixed Bag (FREE)
Wed, 22 Feb 2017 06:00:00 +0800 | Physician's First Watch current issue
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH New findings from the NIH-supported " Testosterone Trials " offer a mixed take on the potential role of testosterone therapy in older men. In the trials, men aged 65 and older with serum testosterone below 275 ng/dL plus sexual or physical dysfunction or reduced vitality were randomized to use testosterone gel (1%) or placebo for 1 year.Among the findings, as reported … (Source: Physician's First Watch current issue)
